Abstract
Candidiasis is the prototypic opportunistic fungal disease. Candida spp. reside most commonly in the gastrointestinal tract1,2 and vagina, where they are normally held in check by as-yet incompletely defined local factors that include competition with the resident bacterial flora and innate effectors of nonspecific mucosal resistance.3,4 Infrequently, but under a wide variety of clinical circumstances, these normally inconspicuous commensals can multiply on or invade through the mucosal surface to initiate local or systemic disease. Various immunologic and nonimmunologic conditions can predispose to such opportunistic infections.5 Among the former are certain malignancies6–8 and the use of cytotoxic or immunosuppressive therapy.9,10 Nonimmunologic predisposing factors include diabetes,11 trauma,12 pregnancy,13 antibiotic therapy,7 and hyperalimentation.14 Not infrequently, such predisposing factors occur in combination.
Chapter PDF
Similar content being viewed by others
Keywords
- Candida Albicans
- Chronic Granulomatous Disease
- Invasive Candidiasis
- Bacille Calmette Guerin
- Systemic Candidiasis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Cohen, R., Roth, E J., Delgado, E., Ahearn, D. G., and Kaiser, M. H., 1969, Fungal flora of the normal human small and large intestine, N. Engl. J. Med. 280:638–641.
Draser, B. S., and Hill, M. J., 1974, Human Intestinal Flora, Academic Press, New York.
Kennedy, M. J., 1989, Regulation of Candida albicans populations in the gastrointestinal tract: mechanisms and significance in GI and systemic candidiasis, Curr. Top. Med. Mycol. 3: 315–402.
Budtz Jorgensen, E., 1990, Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections, Acta Odontol. Scand. 48:61–69.
Domer, J. E., and Carrow, E. W, 1989, Candidiasis, in: Immunology of the Fungal Diseases (R. A. Cox, ed.), CRC Press, Inc., Boca Raton, Florida, pp. 57–91.
Young, R. C., Bennett, J. E., Geelhoed, G. W, and Levine, A. S., 1974, Fungemia with compromised host resistance. A study of 70 cases, Ann. Intern. Med. 80:605–612.
Parker, J. C., Jr., McCloskey, J. J., and Knauer, K. A., 1976, Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host, Am. J. Clin. Pathol. 65:991–1000.
Horn, R., Wong, B., Kiehn, T. E., and Armstrong, D., 1985, Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy, Rev. Infect. Dis. 7:646–655.
Pirsch, J. D., and Maki, D. G., 1986, Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow, Ann. Intern. Med. 104:619–631.
Tollemar, J., Ringden, O., Bostrom, L., Nilsson, B., and Sundberg, B., 1989, Variables predicting deep fungal infections in bone marrow transplant recipients, Bone Marrow Transplantation 4:635–641.
Tapper-Jones, L., Aldred, M. J., Walker, D. M., and Hayes, T. M., 1981, Candidal infections and populations of Candida albicans in the mouths of diabetics, J Clin. Pathol. 34:706–711.
Prasad, J. K., Feller, I., and Thomson, P. D., 1987, A ten-year review of Candida sepsis and mortality in burn patients, Surgery 101:213–216.
Ryley, J. E, 1986, Pathogenicity of Candida albicans with particular reference to the vagina, J. Med. Vet. Mycol. 24:5–22.
Montgomerie, J. Z., and Edwards, J. E., Jr., 1978, Association of infection due to Candida albicans with intravenous hyperalimentation, J. Infect. Dis. 137:197–201.
Karabinis, A., Hill, C., Leclercq, B., Tancrede, C., Baume, D., and Andremont, A., 1988, Risk factors for candidemia in cancer patients: a case-control study, J. Clin. Microbiol. 26: 429–432.
Bross, J., Talbot, G. H., Maislin, G., Hurwitz, S., and Strom, B. L., 1989, Risk factors for nosocomial candidemia: a case-control study in adults without leukemia, Am. J. Med. 87: 614–620.
Odds, F. C., 1988, Candida and Candidosis, Bailliere Tindall, London, pp. 93–114.
Pfaller, M. A., 1988, Nosocomial Candida infections, Curr. Opin. Infect. Dis. 1:764–771.
Rippon, J. W, 1988, Medical Mycology, The Pathogenic Fungi and the Pathogenic Actinomycetes, W. B. Saunders Company, Philadelphia, PA, pp. 532–581.
Spencer, P. M., and Jackson, G. G., 1989, Fungal and mycobacterial infections in patients infected with the human immunodeficiency virus, J. Antimicrob. Chemother. 23(suppl. A): 107–125.
Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M., and Friedland, G. H., 1984, Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome, N. Engl. J. Med. 311:354–358.
Tavitian, A., Raufman, J.-P., and Rosenthal, L. E., 1986, Oral candidiasis as a marker for esophageal candidiasis in the acquired immunodeficiency syndrome, Ann. Intern. Med. 104: 54–55.
Guentzel, M. N., Cole, G. T., and Pope, L. M., 1985, Animal models for candidiasis, Curr. Top. Med. Mycol. 1:57–116.
Kreger-van Rij, N. J. W, 1984, The Yeasts. A Taxonomic Study, Elsevier Science Publishers B. V., Amsterdam, pp. 585–844.
Kiehn, T. E., Edwards, E. E, and Armstrong, D., 1980, The prevalence of yeasts in clinical specimens from cancer patients, Am. J. Clin. Path. 73:518–521.
Wingard, J. R., Merz, W. G., and Saral, R., 1979, Candida tropicalis: a major pathogen in immunocompromised patients, Ann. Intern. Med. 91:539–543.
Meunier-Carpentier, E, Kiehn, T. E., and Armstrong, D., 1981, Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality, Am. j Med. 71:363–370.
Walsh, T. J., and Merz, W. G., 1986, Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis, Am. J. Clin. Pathol. 85:498–502.
Howlett, J. A., 1976, The infection of rat tongue mucosa in vitro with five species of Candida, J. Med. Microbiol. 9:309–316.
Allen, C. M., and Beck, E. M., 1987, Differences in mucosal reaction related to Candida albicans isolates, J. Oral Pathol. 16:89–93.
Martin, M. V, Craig, G. T., and Lamb, D. J., 1984, An investigation of the role of true hypha production in the pathogenesis of experimental oral candidosis, Sabouraudia 22:471–476.
Sobel, J. D., Muller, G., and Buckley, H. R., 1984, Critical role of germ tube formation in the pathogenesis of candidal vaginitis, Infect. Immun. 44:576–580.
Walsh, T. J., and Pizzo, P. A., 1988, Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation, Ann. Rev. Microbiol. 42:517–545.
Hadfield, T. L., Smith, M. B., Winn, R. E., Rinaldi, M. G., and Guerra, C., 1987, Mycoses caused by Candida lusitaniae, Rev. Infect. Dis. 9:1006–1012.
Dick, J. D., Rosenguard, B. R., Merz, W. G., Stuart, R. K., Hutchins, G. M., and Saral, R., 1985, Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii, Ann. Intern. Med. 102:67–68.
Pappagianis, D., Collins, M. S., Hector, R., and Remington, J., 1979, Development of resistance to amphotericin B in Candida lusitaniae infecting a human, Antimicrob. Agents Chemother. 16:123–126.
Hasenclever, H.F., and Mitchell, W. O., 1961, Antigenic studies of Candida. I. Observations of two antigenic groups in Candida albicans,j. Bacteriol. 82:570–573.
Odds, E. C., and Abbott, A. B., 1980, A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species, Sabouraudia 18:301–317.
Odds, E. C., and Abbott, A. B., 1983, Modification and extension of tests for differentiation of Candida species and strains, Sabouraudia 21:79–81.
McCreight, M. C., and Warnock, D. W, 1982, Enhanced differentiation of isolates of Candida albicans using a modified resistogram method, Mykosen 25:589–598.
Polonelli, L., Archibusacci, C., Sestito, M., and Morace, G., 1983, Killer system: a simple method for differentiating Candida albicans strains, J. Clin. Microbiol. 17:774–780.
Roman, M. C., and Linaresicilia, M. J., 1983, Preliminary investigation of Candida albicans biovars, J. Clin. Microbiol. 18:430–431.
Lee, W, Burnie, J., and Matthews, R., 1986, Fingerprinting Candida albicans, j Immunol. Methods 93:177–182.
Phongpaichit, S., Mackenzie, D. W. R., and Fraser, C., 1987, Strain differentiation of Candida albicans by morphotyping, Epidemiol. Infect. 99:421–428.
Magee, B. B., D’Souza, T. M., and Magee, P. T., 1987, Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species, J. Bacteriol. 169:1639–1643.
Scherer, S., and Stevens, D. A., 1987, Application of DNA typing methods to epidemiology and taxonomy of Candida species, j Clin. Microbiol. 25:675–679.
Magee, B. B., and Magee, P. T., 1987, Electrophoretic karyotypes and chromosome numbers in Candida species, j Gen. Microbiol. 133:425–430.
Merz, W. G., Connelly, C., and Hieter, P., 1988, Variation of electrophoretic karyotypes among clinical isolates of Candida albicans,j Clin. Microbiol. 26:842–845.
Vaudry, W. L., Tierney, A. J., and Wenman, W. M., 1988, Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit, J. Infect. Dis. 158:1375–1379.
Burnie, J. P., Odds, E. C., Lee, W, Webster, C., and Williams, J. D., 1985, Outbreak of systemic Candida albicans in intensive care unit caused by cross infection, Brit. Med. J. (Clin. Res.) 290:746–748.
Odds, F. C., Palacio-Hernanz, A., Cuadra, J., and Sanchez, J., 1987, Disseminated Candida infection syndrome in heroin addicts—dominance of a single Candida albicans biotype, J. Med. Microbiol. 32:275–277.
Neely, A. N., Odds, E C., Basatia, B. K., and Holder, I. A., 1988, Characterization of Candida isolates from pediatric burn patients, j Clin. Microbiol. 26:1645–1649.
Fox, B. C., Mobley, H. L. T., and Wade, J. C., 1989, The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts, J. Infect. Dis. 159: 488–494.
Pfaller, M., 1989, Infection control: opportunistic fungal infections—the increasing importance of Candida species, Infect. Control Hosp. Epidemiol. 10:270–273.
Stevens, D. A., Odds, E. C., and Scherer, S., 1990, Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype, Rev. Infect. Dis. 12: 258–266.
Soll, D. R., Staebell, M., Langtimm, C., Pfaller, M., Hicks, J., and Gopala Rao, T. V., 1988, Multiple Candida strains in the course of a single systemic infection, J. Clin. Microbiol. 26: 1448–1459.
Burkholder, P. R., 1943, Vitamin deficiencies in yeasts, Am. j Botany 30:206–211.
Drouhet, E., and Vieu, M., 1957, Facteurs vitaminiques de croissance des Candida, Ann. Inst. Pasteur 92:825–831.
Caroline, L., Taschdjian, C. L., Kozinn, P. J., and Schade, A. L., 1964, Reversal of serum fungistasis by addition of iron, j Invest. Dermatol. 42:415–419.
Masson, P. L., Heremans, J. F., and Schonne, E., 1969, Lactoferrin, an iron-binding protein in neutrophilic leukocytes, J. Exp. Med. 130:643–658.
Bretz, U., and Baggiolini, M., 1974, Biochemical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes, J. Cell Biol. 63:251–269.
Rado, T. A., Wei, X., and Benz, E. J., Jr., 1987, Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis, Blood 70:989–993.
Kirkpatrick, C. H., Green, I., Rich, R. R., and Schade, A. L., 1971, Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms in chronic mucocutaneous candidiasis, J. Infect. Dis. 124:539–544.
McNamara, M. P., Wiessner, J. H., Collins-Lech, C., and Hahn, B. L., 1988, Neutrophil death as a defence mechanism against Candida albicans infections, Lancet 2:1163–1165.
Sohnle, P. G., and Collins-Lech, C., 1990, Comparison of candidacidal and candidastatic activities of human neutrophils, Infect. Immun. 58:2696–2698.
Steinbakk, M., Naess-Andresen, C.-E, Lingaas, E., Dale, I., Brandtzaeg, P., and Fagerhol, M. K., 1990, Antimicrobial actions of calcium binding leucocyte Ll protein, calprotectin, Lancet 336:763–765.
Knight, L., and Fletcher, J., 1971, Growth of Candida albicans in saliva; stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus, J. Infect. Dis. 123: 371–377.
Epstein, J. B., Truelove, E. L., and Izutzu, K. T., 1984, Oral candidiasis: pathogenesis and host defense, Rev. Infect. Dis. 6:96–106.
Fisker, A. V., Schiott, C. R., and Philipsen, H. P., 1982, Short-term oral candidosis in rats, with special reference to the site of infection, Acta Pathol. Microbiol. Immunol. Scand. B 90: 49–57.
Russell, C., Jones, J. H., and Gibbs, A. C. C., 1976, The carriage of Candida albicans in the mouths of rats treated with tetracycline briefly or for a prolonged period, Mycopathologia 58:125–129.
DeMaria, A., Buckley, H., and von Lichtenberg, E, 1976, Gastrointestinal candidiasis in rats treated with antibiotics, cortisone and azathioprine, Infect. Immun. 13:1761–1770.
Cantorna, M. T., and Balish, E., 1990, Mucosal and systemic candidiasis in congenitally immunodeficient mice, Infect. Immun. 58:1093–1100.
Ouellette, A. J., Greco, R. M., James, M., Frederick, D., Naftilan, J., and Fallon, J. T., 1989, Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium, J. Cell Biol. 108:1687–1695.
Selsted, M. E., Szklarek, D., Ganz, T., and Lehrer, R. I., 1985, Activity of rabbit leukocyte peptides against Candida albicans,Infect. Immun. 49:202–206.
Krause, W, Matheis, H., and Wulf, K., 1969, Fungaemia and funguria after oral administration of Candida albicans,Lancet 1:598–599.
Sass, W, Dreyer, H. P., Bockeler, W, Hamelmann, H., and Seifert, J., 1987, Prinzipien der partikelresorption im magen-darm-trakt, Z. Gastroenterol. 25:306–315.
Baine, W. B., Koenig, M. G., and Goodman, J. S., 1974, Clearance of Candida albicans from the bloodstream of rabbits, Infect. Immun. 10:1420–1425.
Bird, D. C., and Sheagren, J. N., 1970, Evaluation of reticuloendothelial system phagocytic activity during systemic Candida albicans infection in mice, Proc. Soc. Exp. Biol. Med. 133:34–37.
Cho, Y. S., and Choi, H. Y., 1979, Opportunistic fungal infection among cancer patients: a ten year autopsy study, Am. J. Clin. Pathol. 72:617–620.
Bach, M. C., Sahyoun, A., Adler, J. L., Schlesinger, R. M., Breman, J., Madras, P., P’eng, E K., and Monaco, A. P., 1973, High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression, Transplant. Proc. 5:549–553.
Louria, D. B., Brayton, R. G., and Finkel, G., 1963, Studies on the pathogenesis of experimental Candida albicans infections in mice, Sabouraudia 2:271–283.
Ruthe, R. C., Andersen, B. R., Cunningham, B. L., and Epstein, R. B., 1978, Efficacy of granulocyte transfusions in control of systemic candidiasis in leukopenic host, Blood 52: 493–498.
Hurtrel, B., Lagrange, P. H., and Michel, J.-C.,1980, Systemic candidiasis in mice. II. Main role of polymorphonuclear leukocytes in resistance to infection, Ann. D’Immunol. 131:105–118.
Cutler, J. E., and Poor, A. H., 1981, Effect of mouse phagocytes on Candida albicans in in vivo chambers, Infect. Immun. 31:1110–1116.
Lehrer, R. I., and Cline, M. J., 1969, Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection, J Clin. Invest. 48:1478–1488.
Cech, P., Papathanassiou, A., Boreux, G., Roth, P., and Miescher, P. A., 1979, Hereditary myeloperoxidase deficiency, Blood 53:403–411.
Cech, P., Stalder, H., Widmann, J.J., Rohner, A., and Miescher, P. A., 1979, Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess, Am. J. Med. 66:149–153.
Moosman, K., and Bojanovsky, A., 1975, Rezidivierende candidosis bei myeloperoxydase mangel, Monatschr. Kinderheilkd. 123:408–409.
Parry, M. E, Root, R. K., Metcalf, J. A., Delaney, K. K., Kaplow, L. S., and Richar, W. J., 1981, Myeloperoxidase deficiency. Prevalence and clinical significance, Ann. Intern. Med. 95: 293–301.
Catovsky, D., Galton, D. A., Robinson, J., 1972, Myeloperoxidase-deficient neutrophils in acute myeloid leukaemia, Scand. J. Haematol. 9:142–148.
Bendix-Hansen, K., and Nielsen, H. K., 1983, Myeloperoxidase-deficient polymorphonuclear leucocytes (II). Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse, Scand. J Haematol. 31:5–8.
Bendix-Hansen, K., Kerndrup, G., and Pedersen, B., 1986, Myeloperoxidase-deficient polymorphonuclear leucocytes (VI): Relation to cytogenetic abnormalities in primary myelodysplastic syndromes, Scand. J. Haematol. 36:3–7.
Lehrer, R. I., Goldberg, L. S., Apple, M. A., and Rosenthal, N. P., 1972, Refractory megaloblastic anemia with myeloperoxidase-deficient neutrophils, Ann. Intern. Med. 76: 447–453.
Lehrer, R. I., 1972, Functional aspects of a second mechanism of candidacidal activity by human neutrophils, J. Clin. Invest. 51:2566–2572.
Lehrer, R. I., Hanifin, J., and Cline, M. J., 1969, Defective bactericidal activity in myeloperoxidase-deficient human neutrophils, Nature (Lond.) 223:78–79.
Lehrer, R. I., 1975, The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms, J. Clin. Invest. 55:338–346.
Diamond, R. D., Krzesicki, R., and Jao, W, 1978, Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro, J Clin. Invest. 61:349–359.
Rosner, E, Valmont, I., Kozinn, P. J., and Caroline, L., 1970, Leukocyte function in patients with leukemia, Cancer 25:835–842.
Lehrer, R. I., and Cline, M. J., 1971, Leukocyte candidacidal activity and resistance to systemic candidiasis in patients with cancer, Cancer 27:1211–1217.
Goldman, J. M., and Th’ng, K. H., 1973, Phagocytic function of leukocytes from patients with acute myeloid and chronic granulocytic leukaemia, Br. J. Haematol. 25:299–308.
Bjerknes, R., Vindenes, H., and Laerum, O. D., 1990, Altered neutrophil functions in patients with large burns, Blood Cells 16:127–141.
El-Maalem, H., and Fletcher, J., 1976, Defective neutrophil function in chronic granulocytic leukaemia, Br. J. Haematol. 66:95–103.
Child, J. A., Martin, S., Cawley, J. C., and Ghoniem, A. T. M., 1978, Defective microbicidal function of neutrophils in haematological malignancies and lymphomas: correction by levamisole in vitro, Biomedicine 29:159–161.
Uberti-Foppa, C., Franzetti, F., Hegri, C., Novati, R., Cinque, P., Privitera, G., Parente, E, Crocchiolo, P., and Lazzarin, A., 1987, Role of PMN’s candidacidal activity in the pathogenesis of AIDS-related systemic candidiasis, Bull. Ist. Sieroter. Milan 66:471–478.
Xanthou, M., Valassi-Adam, E., Kintsonidou, E., and Matsaniotis, N., 1975, Phagocytosis and killing ability of Candida albicans by blood leucocytes of healthy term and preterm babies, Arch. Dis. Child 50:72–75.
Quie, P. G., and Chilgren, R. A., 1971, Acute disseminated and chronic mucocutaneous candidiasis, Semin. Hematol. 8:227–242.
Oseas, R., and Lehrer, R. I., 1978, A micromethod for measuring neutrophil candidacidal activity in neonates, Pediatr. Res. 12:828–829.
Tuck, R., Burke, V., Gracey, M., Malajczuk, A., and Sunoto, 1979, Defective Candida killing in childhood malnutrition, Arch. Dis. Child. 54:445–447.
Boyne, R., Arthur, J. R., and Wilson, A. B., 1986, An in vivo and in vitro study of selenium deficiency and infection in rats, J. Comp. Pathol. 96:379–386.
Kernbaum, S., and Vilde, J.-L., 1974, Etude du pouvoir candidacide des polynucleaires neutrophiles humains, Pathol. Biol. (Paris) 22:61–66.
El Falaky, I. H., and Shoukry, H. M., 1977, Phagocytosis and intracellular killing of Candida albicans by polymorphonuclear leucocytes in thalassaemia, J. Egyptian Public Health Assoc. 52:317–329.
Drutz, D. J., and Lehrer, R. I., 1978, Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function, Am. J. Med. Sci. 276:77–92.
Edwards, J. E., Jr., Rotrosen, D., Fontaine, J. W, Haudenschild, C. C., and Diamond, R. D., 1987, Neutrophil-mediated protection of cultured human vascular endothelial cells from damage by growing Candida albicans hyphae, Blood 69:1450–1457.
Retrosen, D., Edwards, J. E., Jr., Gibson, T. R., Moore, J. C., Cohen, A. H., and Green, I., 1985, Adherence of Candida to cultured vascular endothelial cells: mechanisms of attachment and endothelial cell penetration, J. Infect. Dis. 152:1264–1274.
Davies, R. R., and Denning, T. J. V., 1972, Candida albicans and the fungicidal activity of the blood, Sabouraudia 10:301–312.
Lehrer, R. I., and Cline, M. J., 1969, Interaction of Candida albicans with human leukocytes and serum, J. Bacteriol. 98:996–1004.
Edwards, J. E., Jr., Lehrer, R. I., Stiehm, E. R., Fischer, T. J., and Young, L. S., 1978, Severe candidal infections. Clinical perspective, immune defense mechanisms, and current concepts of therapy, Ann. Intern. Med. 89:91–106.
Ray, T. L., and Wuepper, K. D., 1976, Activation of the alternative (properdin) pathway of complement by Candida albicans and related species, J. Invest. Derm. 67:700–703.
Denning, T. J. V., and Davies, R. R., 1973, Candida albicans and the chemotaxis of polymorphonuclear neutrophils, Sabouraudia 11:210–221.
Weeks, B. A., Escobar, M. R., Hamilton, P. B., and Fueston, V. M., 1976, Chemotaxis of polymorphonuclear neutrophilic leukocytes by mannan-enriched preparations of Candida albicans, Adv. Exp. Med. Biol. 73:161–169.
Ray, T. L., Hanson, A., Ray, L. E, and Wuepper, K. D., 1979, Purification of a mannan from Candida albicans which activates serum complement, J. Invest. Dermatol. 73:269–274.
Cutler, J. E., 1977, Chemotactic factor produced by Candida albicans, Infect. Immun. 18: 568–573.
Morelli, R., and Rosenberg, L. T., 1971, The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes, J. Immunol. 107:476–480.
Yamamura, M., and Valdimarsson, H., 1977, Participation of C3 in intracellular killing of Candida albicans, Scand. J Immunol. 6:591–594.
Ferrante, A., and Thong, Y. H., 1979, Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans, Sabouraudia 17:293–297.
Kernbaum, S., 1975, Pouvoirs phagocytaire et fongicide envers Candida albicans des polynucleaires neutrophiles humains en presence de serum depourvu de C3 et C4, Ann. Microbiol. (Inst. Pasteur). 126A:75–81.
Morrison, R. P., and Cutler, J. E., 1981, In vitro studies of the interaction of murine phagocytic cells with Candida albicans, J. Reticuloendothel. Soc. 29:23–24.
Sinski, J. T., Reed, G. L., Kelley, L. M., and Le Vebvre, R., 1973, Macrophage migration technique using coccidioidin, Infect. Immun. 7:226–230.
Solomkin, J. S., Mills, E. L., Giebink, G. S., Nelson, R. D., Simmons, R. L., and Quie, P. G., 1978, Phagocytosis of Candida albicans by human leukocytes: opsonic requirements, J. Infect. Dis. 137:30–37.
Leijh, P. C., Barselaar, M. T., and van Furth, R., 1977, Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes, Infect. Immun. 17:313–318.
Ginsburg, I., Sela, M. N., Morag, A., Ravid, Z., Duchan, Z., Ferne, M., Rabinowitz-Bergner, S., Thomas, P. R, Davies, R, Niccols, J., Humes, J., and Bonney, R., 1981, Role of leukocyte factors and cationic polyelectrolytes in phagocytosis of group A streptococci and Candida albicans by neutrophils, macrophages, fibroblasts and epithelial cells: modulation by anionic polyelectrolytes in relation to pathogenesis of chronic inflammation, Inflammation 5:289–312.
Pereira, H. A., and Hosking, C. S., 1984, The role of complement and antibody in opsonization and intracellular killing of Candida albicans, Clin. Exp. Immunol. 57:307–314.
Sandhu, D. K., Sandhu, R. S., Damodaran, V. N., and Randhawa, H. S., 1970, Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species, Sabouraudia 8:32–38.
Hurley, D. L., Balow, J. E., and Fauci, A. S., 1975, Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection and immunity, J Infect. Dis. 132:393–398.
Laforce, E. M., Mills, D. M., Iverson, K., Cousins, R., and Everett, E. D., 1975, Inhibition of leukocyte candidacidal activity by serum from patients with disseminated candidiasis, J. Lab. Clin. Med. 86:657–666.
Walker, S. M., and Urbaniak, S. J., 1980, A serum-dependent defect of neutrophil function in chronic mucocutaneous candidiasis, J. Clin. Pathol. 33:370–372.
Fleischmann, J., Selsted, M. E., and Lehrer, R. I., 1985, Opsonic activity of MCP-1 and MCP-2, cationic peptides from rabbit alveolar macrophages, Diagn. Microbiol. Infect. Dis. 3: 233–242.
Hector, R. E, Domer, J. E., and Carrow, E. W, 1982, Immune responses to Candida albicans in genetically-distinct mice, Infect. Immun. 38:1020–1028.
Lyon, E. L., Hector, R. E, and Domer, J. E., 1986, Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component, J. Med. Vet. Mycol. 24:359–367.
Gelfand, J. A., Hurley, D. L., Fauci, A. S., and Frank, M. M., 1978, Role of complement in host defense against experimental disseminated candidiasis, J. Infect. Dis. 138:9–16.
Lehrer, R. I., 1970, Measurement of candidacidal activity of specific leukocyte types in mixed cell populations. I. Normal, myeloperoxidase-deficient, and chronic granulomatous disease neutrophils, Infect. Immun. 2:42–47.
Husseini, R. H., Hoadley, M. E., Hutchinson, J. J. P., Penn, C. W, and Smith, H., 1985, Intracellular killing of Candida albicans by human polymorphonuclear leucocytes: comparison of three methods of assessment, J. Immunol. Methods 81:215–221.
Lehrer, R. I., 1971, Inhibition by sulfonamides of the candidacidal activity of human neutrophils, J. Clin. Invest. 50:2498–2505.
Schmid, L., and Brune, K., 1974, Assessment of phagocytic and antimicrobial activity of human granulocytes, Infect. Immun. 10:1120–1126.
Vecchiarelli, A., Bistoni, E, Cenci, E., Perito, S., and Cassone, A., 1985, In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity, Sabouraudia 23:377–387.
Scherwitz, C., and Martin, R., 1979, The phagocytosis of Candida albicans blastospores and germ tubes by polymorphonuclear leukocytes, Dermatologia 159:12–23.
Schuit, K. E., 1979, Phagocytosis and intracellular killing of pathogenic yeast by human monocytes and neutrophils, Infect. Immun. 24:932–938.
Cockayne, A., and Odds, E. C., 1984, Interactions of Candida albicans yeast cells, germ tubes, and hyphae with human polymorphonuclear leucocytes in vitro, j Gen. Microbiol. 130: 465–471.
Brummer, E., McEwen, J. G., and Stevens, D. A., 1986, Fungicidal activity of murine inflammatory polymorphonuclear neutrophils: comparison with murine peripheral blood PMN, Clin. Exp. Immunol. 66:681–690.
Kernbaum, S., 1975, Pouvoir candidacide des polynucleaires neutrophiles humains et chimiotherapie antibacterienne, Pathol. Biol. 22:789–794.
Ferrari, E A., Pagani, A., Marconi, M., Stefanoni, R., and Siccardi, A. G., 1980, Inhibition of candidacidal activity of human neutrophil leukocytes by aminoglucoside antibiotics, Antimicrob. Agents Chemother. 17:87–88.
Roilides E., Walsh, T. J., Rubin, M., Venzon, D., and Pizzo, P. A., 1990, Effects of antifungal agents on the function of human neutrophils in vitro, Antimicrob. Agents Chemother. 34: 196–201.
Meshulam, T., Diamond, R. D., Lyman, C. A., Wysong, D. R., and Melnick, D. A., 1988, Temporal association of calcium mobilization, inositol triphosphate generation, and superoxide anion release by human neutrophils activated by serum opsonized and nonopsonized particulate stimuli, Biochem. Biophys. Res. Commun. 150:532–539.
Wilson, R. M., and Reeves, W G., 1986, Neutrophil phagocytosis and killing in insulin-dependent diabetes, Clin. Exp. Immunol. 63:478–484.
Chan, C. K., and Balish, E., 1978, Inhibition of granulocyte phagocytosis of Candida albicans by amphotericin B, Can. J. Microbiol. 24:363–364.
Belches-, R. W, Carney, J. E, and Monahan, F. G., 1973, An electron microscopic study of phagocytosis of Candida albicans by polymorphonuclear leukocytes, Lab. Invest. 29: 620–627.
Richardson, M., and Smith, H., 1983, Ultrastructural features of phagocytosis and intracellular killing of Candida albicans by mouse polymorphonuclear phagocyte monolayers, Mycopathologia 83:97–102.
Cech, P., and Lehrer, R. I., 1984, Heterogeneity of human neutrophil phagolysosomes: functional consequences for candidacidal activity, Blood 64:147–151.
Levitz, S. M., DiBenedetto, D. J., and Diamond, R. D., 1987, A rapid fluorescent assay to distinguish attached from phagocytized yeast particles, J. Immunol. Methods 101:37–42.
Klebanoff, S. J., 1980, Oxygen metabolism and the toxic properties of phagocytes, Ann. Intern. Med. 93:480–489.
Weiss, S. J., Test, S. T., Eckmann, C. M., Roos, D., and Regiani, S., 1986, Brominating oxidants generated by human eosinophils, Science 234:200–203.
Lehrer, R. I., 1971, Measurement of candidacidal activity of specific leukocyte types in mixed cell populations: II. Normal and chronic granulomatous disease eosinophils, Infect. Immun. 3:800–802.
Foote, C. S., Goyne, T. E., and Lehrer, R. I., 1983, Assessment of chlorination by human neutrophils, Nature 301:715–716.
Weiss, S. J., Klein, R., Slivka, A., and Wei, M., 1982, Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation, J. Clin. Invest. 70:598–607.
Lehrer, R. I., 1969, Antifungal effects of peroxidase systems, J. Bacteriol. 99:361–365.
Lehrer, R. I., and Jan, R. G., 1970, Interaction of Aspergillus fumigatus spores with human leukocytes and serum, Infect. Immun. 1:345–350.
Diamond, R. D., Clark, R. A., and Haudenschild, C. C., 1980, Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro, J. Clin. Invest. 66:908–917.
Wagner, D. K., Collins-Lech, C., and Sohnle, P. G., 1986, Inhibition of neutrophil killing of Candida albicans pseudohyphae by substances which quench hypochlorous acid and chlor-amines, Infect. Immun. 51:731–735.
Beilke, M. A., Collins-Lech, C., and Sohnle, P. G., 1989, Candidacidal activity of the neutrophil myeloperoxidase system can be protected from excess hydrogen peroxide by the presence of ammonium ion, Blood 73:1045–1049.
Kolotila, M. P., and Diamond, R. D., 1990, Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans W0–1, Infect. Immun. 58:1174–1179.
Babior, B. M., 1988, The respiratory burst oxidase, in, Phagocytic defects II (Curnutte, J. J., ed). Hematol. Oncol Clin. North Am. 2:201–212.
Clark, R. A., 1990, Perspective: The human neutrophil respiratory burst oxidase, J. Infect. Dis. 161:1140–1147.
Cohen, M. S., Isturiz, R. E., Malech, H. L., Root, R. K., Wilfert, C. M., Gutman, L., and Buckley, R. H., 1981, Fungal infection in chronic granulomatous disease—the importance of the phagocyte in defense against fungi, Am. j Med. 71:59–66.
Lehrer, R. I., Ladra, K. M., and Hake, R. B., 1975, Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbi;, and guinea pig leukocytes, Infect. Immun. 11:1226–1234.
Levitz, S. M., and Diamond, R. D., 1984, Killing of Aspergillus fumigates spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system, Infect. Immun. 43:1100–1102.
Lehrer, R. I., Szklarek, D., Ganz, T., and Selsted, M. E., 1985, Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity, Infect. Immun. 49: 207–211.
Lehrer, R. I., Szklarek, D., Ganz, T., and Selsted, M. E., 1986, Synergistic activity of rabbit granulocyte peptides against Candida albicans, Infect. Immun. 52:902–904.
Diamond, R. D., and Krzesicki, R., 1978, Mechanism of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro, J. Clin. Invest. 61:360–369.
Levitz, S. M., Lyman, C. A., Murata, T., Sullivan, J. A., Mandell, G. L., and Diamond, R. D., 1987, Cytosolic calcium changes in individual neutrophils stimulated by opsonized and unopsonized Candida albicans hyphae, Infect. Immun. 55:2783–2788.
Lyman, C. A., Simons, E. R., Melnick, D. A., and Diamond, R. D., 1987, Unopsonized Candida albicans hyphae stimulate a neutrophil respiratory burst and a cytosolic calcium flux without membrane depolarization, j Infect. Dis. 156:770–776.
Lyman, C. A., Simons, E. R., Melnick, D. A., and Diamond, R.D., 1988, Induction of signal transduction in human neutrophils by Candida albicans hyphae: the role of pertussis toxin-sensitive guanosine triphosphate-binding proteins, J. Infect. Dis. 158:1056–1064.
Kolotila, M. R, and Diamond, R. D., 1988, Stimulation of neutrophil actin polymerization and degranulation by opsonized and unopsonized Candida albicans hyphae and zymosan, Infect. Immun. 56:2016–2022.
Wysong, D. R., Lyman, C. A., and Diamond, R. D., 1989, Independence of neutrophil respiratory burst oxidant generation from the early cytosolic calcium response after stimulation with unopsonized Candida albicans hyphae, Infect. Immun. 57:1499–1505.
Diamond, R. D., and Noble, L., 1990, Patterns of guanine nucleotide exchange reflecting disparate neutrophil activation pathways by opsonized and unopsonized Candida albicans hyphae, J. Infect. Dis. 162:262–265.
Sawyer, D. W, Donowitz, G. R., and Mandell, G. L., 1989, Polymorphonuclear neutrophils: an effective antimicrobial force, Rev. Infect. Dis. 11:S1532–S1544.
Lehrer, R. I., and Ganz, T., 1990, Antimicrobial polypeptides of human neutrophils, Blood 76:2169–2181.
Zeya, H. I., and Spitznagel, J. K., 1966, Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities, J. Bacteriol. 91:750–754.
Lehrer, R. I., Ganz, T., and Selsted, M. E., 1990, Defensins: natural peptide antibiotics from neutrophils, ASM News 56:315–318.
Ganz, T., Selsted, M. E., and Lehrer, R. I., 1990, Defensins, Bur. j Haematol. 44:1–8.
Lehrer, R. I., Ganz, T., Szklarek, D., and Selsted, M. E., 1988, Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations, J. Clin. Invest. 81:1829–1835.
Rice, W. G., Ganz, T., Kinkade, J. M., Jr., Selsted, M. E., Lehrer, R. I., and Parmley, R. T., 1987, Defensin-rich dense granules of human neutrophils, Blood 70:757–765.
Wilde, C. G., Griffith, J. E., Marra, M. N., Snable, J. L., and Scott, R. W, 1989, Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family, J. Biol. Chem. 264:11200–11203.
Selsted, M. E., Brown, D. M., DeLange, R. J., Harwig, S. S., and Lehrer, R. I., 1985, Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils, J. Biol. Chem. 260: 4579–4584.
Eisenhauer, P. B., Harwig, S. S. L., Szklarek, D., Ganz, T., Selsted, M. E., and Lehrer, R. I., 1989, Purification and antimicrobial properties of three defensins from rat neutrophils, Infect. Immun. 57:2021–2027.
Eisenhauer, P., Harwig, S. S. S. L., Szklarek, D., Ganz, T., and Lehrer, R. I., 1990, Polymorphic expression of defensins in neutrophils from outbred rats, Infect. Immun. 58: 3899–3902.
Kagan, B. L., Selsted, M. E., Ganz, T., and Lehrer, R. I., 1990, Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes, Proc. Natl. Acad. Sci. USA 87:210–214.
Odeberg, H., and Olsson, I., 1975, Antibacterial activity of cationic proteins from human granulocytes, J. Clin. Invest. 56:1118–1124.
Odeberg, H., and Olsson, I., 1976, Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin-like cationic protein, Infect. Immun. 14:1276–1283.
Gabay, J. E., Scott, R. W, Campanelli, D., Griffith, J., Wilde, C., 1989, Antibiotic proteins of human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. USA 86:5610–5614.
Campanelli, D., Detmers, P. A., Nathan, C. E, Gabay, J. E., 1990, Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties, J. Clin. Invest. 85;904–915.
Wilde, C. G., Snable, J. L., Griffith, J. E., Scott, R. W, 1990, Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase, J. Biol. Chem. 265:2038–2041.
Shafer, W. M., Pohl, J., Onunka, V. C., Bangalore, N., and Travis, J., 1990, Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide, J. Biol. Chem. 266:112–116.
Arnold, R. R., Brewer, M., and Gauthier, J. J., 1980, Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms, Infect. Immun. 28:893–898.
Collins, M. S., and Pappagianis, D., 1973, Effects of lysozyme and chitinase on the spherules of Coccidioides immitis in vitro, Infect. Immun. 7:817–822.
Gadebusch, H. H., and Johnson, A. G., 1966, Natural host resistance to infection with Cryptococcus neoformans. IV. The effect of some cationic proteins on the experimental disease, J. Infect. Dis. 116:551–565.
Rausch, P. G., and Moore, T. G., 1975, Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison, Blood 46:913–919.
Marquis, G., Montplaisir, S., Garzon, S., Strykowski, H., and Auger, P., 1982, Fungitoxicity of muraminidase: ultrastructural damage to Candida albicans, Lab. Invest. 46:627–636.
Kamaya, T., 1970, Lytic action of lysozyme on Candida albicans, Mycopathol. Mycol. Appl. 42: 197–207.
Ray, T. L., and Wuepper, K. D., 1976, Experimental cutaneous candidiasis in rodents, J. Invest. Derm. 66:29–33.
Ray, T. L., and Wuepper, K. D., 1978, Experimental cutaneous candidiasis in rodents II. Role of the stratum corneum barrier and serum complement as a mediator of a protective inflammatory response, Arch. Dermatol. 114:539–543.
Louria, D. B., and Brayton, R. G., 1964, Behavior of Candida cells within leukocytes, Proc. Soc. Exp. Biol. Med. 115:93–98.
Diamond, R. D., Oppenheim, E, Nakagawa, Y., Krzesicki, R., and Haudenschild, C. C., 1980, Properties of a product of Candida albicans hyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro, J. Immunol. 125:2797–2804.
Smail, E. H., Melnick, D. A., Ruggeri, R., and Diamond, R. D., 1988, A novel natural inhibitor from Candida albicans hyphae causing dissociation of the neutrophil respiratory burst response to chemotactic peptides from other post-activating events, J. Immunol. 140: 3893–3899.
Smail, E. H., Kolotila, M. P., Ruggeri, R., and Diamond, R. D., 1989, Natural inhibitor from Candida albicans blocks release of azurophil and specific granule contents by chemotactic peptide-stimulated human neutrophils, Infect. Immun. 57:689–692.
Hilger, A. E., and Danley, D. L., 1980, Alteration of polymorphonuclear leukocyte activity by viable Candida albicans, Infect. Immun. 27:714–720.
Danley, D. L., Hilger, A. E., Winkel, C. A., 1983, Generation of hydrogen peroxide by Candida albicans and influence on murine polymorphonuclear leukocyte activity, Infect. Immun. 40:97–102.
Heidenreich, E, and Dierich, M. P., 1985, Candida albicans and Candida stellatoidea in contrast to other Candida species bind iC3b and C3d but not C3b, Infect. Immun. 50:598–600.
Edwards, J. E., Jr., Gaither, T. A., O’Shea, J. J., Rotrosen, D., Lawley, T. J., Wright, S. A., Frank, M. M., and Green, I., 1986, Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors, J. Immunol. 137: 3577–3583.
Calderone, R. A., Linehan, L., Wadsworth, E., and Sandberg, A. L., 1988, Identification of C3d receptors on Candida albicans, Infect. Immun. 56:252–258.
Gilmore, B. J., Retsinas, E. M., Lorenz, J. S., and Hostetter, M. K., 1988, An iC3b receptor on Candida albicans: structure, function and correlates for pathogenicity, J Infect. Dis. 157: 38–46.
Eigentler, A., Schulz, T. E, Larcher, C., Breitwieser, E. M., Myones, B. L., Petzer, A. L., and Dierich, M. P., 1989, C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3, Infect. Immun. 57: 616–622.
Hostetter, M. K., 1990, Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans, Diabetes 39:271–275.
Hostetter, M. K., Lorenz, J. S., Preus, L., Kendrick, K. E., 1990, The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose, J. Infect. Dis. 161:761–768.
Slutsky, B., Buffo, J., and Soll, D. R., 1985, High-frequency switching of colony morphology in Candida albicans, Science 230:666–669.
Soll, D. R., Slutsky, B., Mackenzie, S., Langtimm, C., and Staebell, M., 1987, Two newly discovered switching systems in Candida albicans and their possible role in oral candidiasis, in: Oral mucosal diseases: biology, etiology, and therapy,(I. C. Mackenzie, C. A. Squier, and E. Dabelsteen, eds.), Laegeforeningen Forlag, Copenhagen, pp. 52–59.
Ishikawa, T., Dalton, A. C., and Arbesman, C. E., 1972, Phagocytosis of Candida albicans by eosinophilic leukocytes, j Allergy Clin. Immunol. 49:311–315.
Ishikawa, T., Yu, M. C., and Arbesman, C. E., 1972, Electron microscopic demonstration of phagocytosis of Candida albicans by human eosinophilic leukocytes, J. Allergy Clin. Immunol. 50:183–187.
Lehrer, R. I., 1981, Ingestion and destruction of Candida albicans, in: Methods for Studying Mononuclear Phagocytes, (D. A. Adams, H. Koren, and P. Edelson, eds.), Academic, New York, pp. 693–708.
Estevez, M. E., Sen, L., Vadez, R., and Balina, L. M., 1979, Defective blood mononuclear phagocyte function in patients with leprosy, Int. j Leprosy 47:575–579.
Estevez, M. E., Ballart, I. J., Diez, R. A., Planes, N., Scaglione, C., and Sen, L., 1986, Early defect of phagocytic cell function in subjects at risk for acquired immunodeficiency syndrome, Scand. J Immunol. 24:215–221.
Cohen, A. B., and Cline, M. J., 1971, The human alveolar macrophage: isolation, cultivation in vitro and studies of morphologic and functional characteristics, J. Clin. Invest. 50:1390–1398.
Kemmerich, B., Rossing, T. H., and Pennington, J. E., 1987, Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon, Am. Rev. Respir. Dis. 136:266–270.
Territo, M. C., and Golde, D. W, 1979, The function of human alveolar macrophages, J. Reticuloendothel. Soc. 25:111–120.
Winston, D. J., Territo, M. C., Ho, W. G., Miller, M. J., Gale, R. P., and Golde, D. W, 1982, Alveolar macrophage dysfunction in human bone marrow transplant recipients, Am. J. Med. 73:859–866.
Golde, D. W, Territo, M., Finley, T. N., and Cline, M. J., 1976, Defective lung macrophages in pulmonary alveolar proteinasis, Ann. Intern. Med. 85:304–309.
Robinson, J. E., Harvey, B. A. M., and Soothill, J. E, 1978, Phagocytosis and killing of bacteria and yeast by human milk cells after opsonisation in aqueous phase of milk, Br. Med. J. 1:1443–1445.
Taschdjian, C. L., Toni, E. E, Hsu, K. C., Seelig, M. S., Cuesta, M. B., and Kozinn, P. J., 1971, Immunofluorescence studies of Candida in human reticuloendothelial phagocytes: implications for immunogenesis and pathogenesis of systemic candidiasis, Am. J. Clin. Pathol. 56: 50–58.
Odegaard, A., Viken, K. E., and Lamvik, J., 1974, Structural and functional properties of blood monocytes cultured in vitro, Acta Pathol. Microbiol. Scand. Sect. G. 82:223–234.
Lehrer, R. I., 1970, The fungicidal activity of human monocytes: a myeloperoxidase-linked mechanism, Clin. Res. 18:408–413.
Sasada, M., Kubo, A., Nishimura, T., Kakita, T., Moriguchi, T., Yamamoto, K., and Uchino, H., 1987, Candidacidal activity of monocyte-derived human macrophages: relationship between Candida killing and oxygen radical generation by human macrophages, J. Leukoc. Biol. 41:289–294.
Bourne, H. R., Lehrer, R. I., Cline, M. J., and Melmon, K. L., 1971, Cyclic 3’,5’-adenosine monophosphate in the human leukocyte: synthesis, degradation, and effects on neutrophil candidacidal activity, j Clin. Invest. 50:920–929.
Odegaard, A., and Lamvik, J., 1976, The effect of phenylbutazone and chloramphenicol on phagocytosis of radiolabelled Candida albicans by human monocytes cultured in vitro, Acta Pathol. Microbiol. Scand. Sect. C 84:37–44.
Louria, D. B., Fallon, N., and Browne, H. G., 1960, The influence of cortisone on experimental fungus infections in mice, J. Clin. Invest. 39:1435–1449.
Diamond, R. D., 1981, Mechanisms of host resistance to Candida albicans. In Microbiology 1981, American Society for Microbiology, Washington, D. C., pp. 200–204.
Rinehart, J. J., Sagone, A. L., Balcerzak, S. P., Ackerman, G. A., and LoBuglio, A. E, 1975, Effects of corticosteroid therapy on human monocyte function, N. Engl. J Med. 292:236–241.
Hammerstrom, J., and Unsgaard, G., 1979, In vitro influence of endotoxin on human mononuclear phagocyte structure and function, Acta Pathol. Microbiol. Scand. Sect. C 87: 381–389.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S. L., Daher, K., Bainton, D. E, and Lehrer, R. I., 1985, Defensins: natural peptide antibiotics of human neutrophils, J. Clin. Invest. 76: 1427–1435.
Campbell, E. J., Silverman, E. K., and Campbell, M. A., 1989, Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli and heterogeneity in elastase-mediated proteolytic activity, J. Immunol. 143:2961–2968.
Hurtrel, B., and Lagrange, P. H., 1981, Comparative effects of carrageenan on systemic candidiasis and listeriosis in mice, Clin. Exp. Immunol. 44:355–358.
Lee, K. W, and Balish, E., 1983, Systemic candidosis in silica-treated athymic and euthymic mice, Infect. Immun. 41:902–907.
Sinha, B. K., Monga, D. P., and Prasad, S., 1987, Studies of the role of macrophages in experimental candidosis in mice, Mykosen 30:105–112.
Baghian, A., and Lee, K. W, 1988, Role of activated macrophages in resistance to systemic candidosis, J. Leukoc. Biol. 44:166–171.
Cheers, C., and Waller, R., 1975, Activated macrophages in congenitally athymic “nude” mice and in lethally irradiated mice, J Immunol. 115:844–847.
Cutler, J. E., 1976, Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice, J. Reticuloendothel. Soc. 19:121–124.
Poor, A. H., and Cutler, J.E., 1981, Analysis of an in vivo model to study the interaction of host factors with Candida albicans, Infect. Immun. 31:1104–1109.
Bistoni, E, Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P., and Cassone, A., 1986, Evidence for macrophage-mediated protection against lethal Candida albicans infection, Infect. Immun. 51:668–674.
Chow, H. S., Sarpel, S. C., and Epstein, R. B., 1980, Pathophysiology of Candida albicans meningitis in normal, neutropenic and granulocyte transfused dogs, Blood 55:546–551.
Bistoni, E, Baccarini, M., Blasi, E., Marconi, P., Puccetti, P., and Garaci, E., 1983, Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice, Infect. Immun. 40:46–55.
Fromtling, R. A., Abruzzo, G. K., and Giltinan, D. M., 1987, Candida tropicales infection in normal, diabetic, and neutropenic mice, J. Clin. Microbiol. 25:1416–1420.
van’t Wout, J. W, Linde, I., Leijh, P. C. J., and van Furth, R., 1988, Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection, Eur. J. Clin. Microbiol. Infect. Dis. 7:736–741.
Sawyer, R. T., and Harmsen, A. G., 1989, The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans, Mycopathologia 108:95–105.
Oblack, D. L., Schwarz, J., and Holder, I. A., 1979, Enhancement of tissue damage by Candida albicans in cortisone or nitrogen mustard-treated mice, Can. J Microbiol. 25:1015–1020.
Nugent, K. M., and Onofrio, J. M., 1984, Pulmonary clearance of Candida albicans in neutropenic mice, J. Infect. Dis. 149:1020.
Hasenclever, H. E, and Corley, E. J., 1968, Enhancement of acquired resistance in murine candidiasis by Bordetella pertussis vaccine, Sabouraudia 6:289–295.
Marra, S., and Balish, E., 1974, Immunity to Candida albicans induced by Listeria monocytogenes, Infect. Immun. 10:72–82.
Sher, N. A., Chaparas, S. D., Greenberg, L. E., and Bernard, S., 1975, Effects of BCG, Corynebacterium parvum and methanol-extraction residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infection in immunosuppressed mice, Infect. Immun. 12:1325–1330.
Rogers, T. J., and Balish, E., 1977, The role of activated macrophages in resistance to experimental renal candidiasis, J. Reticuloendothel. Soc. 22:309–318.
Sawyer, R. T., Moon, R. J., and Beneke, E. S., 1981, Trapping and killing of Candida albicans by Corynebacterium parvum-activated livers, Infect. Immun. 32:945–950.
Cummings, N. P., Pabst, M. J., and Johnston, R. B., Jr., 1980, Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide, j Exp. Med. 152:1659–1669.
Fraser-Smith, E. B., Waters, R. V., and Matthews, T. R., 1982, Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice, Infect. Immun. 35:105–110.
Fraser-Smith, E. B., Eppstein, D. A., Larsen, M. A., and Matthews, T. R., 1983, Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection, Infect. Immun. 39:172–178.
Baccarini, M., Blasi, E., Puccetti, P., and Bistoni, E, 1983, Phagocytic killing of Candida albicans by different murine effector cells, Sabouraudia 21:271–286.
Baccarini, M., Bistoni, E, and Lohmann-Matthes, M. L., 1986, Organ-associated macrophage precursor activity: isolation of candidacidal and tumoricidal effectors from the spleens of cyclophosphamide-treated mice, J. Immunol. 136:837–843.
Decker, T., Baccarini, M., and Lohmann-Matthes, M. L., 1986, Liver-associated macrophage precursors as natural cytotoxic effectors against Candida albicans and Yac-1 cells, Eur. j Immunol. 16:693–699.
Baccarini, M., Bistoni, E, and Lohmann-Matthes, M.-L., 1985, In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells, j Immunol. 134:2658–2665.
Decker, T, Lohmann-Matthes, M. L., and Baccarini, M., 1986, Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans, Infect. Immun. 54: 477–486.
Meister, H., Heymer, B., Schafer, H., and Haferkamp, 0., 1977, Role of Candida albicans in granulomatous tissue reactions. II. In vivo degradation of C. albicans in hepatic macrophages of mice, J. Infect. Dis. 135:235–242.
Lehrer, R. I., Ferrari, L. G., Patterson-Delafield, J., and Sorrell, T., 1980, Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans, Infect. Immun. 28: 1001–1008.
Thaler, M., Pastakia, B., Shawker, T. H., O’Leary, T., Pizzo, P. A., 1988, Hepatic candidiasis in cancer patients: the evolving picture of the syndrome, Ann. Intern. Med. 108:88–100.
Carstensen, H., Widding, E., Storm, K., Ostergaard, E., Herlin, T., 1990, Hepatosplenic candidiasis in children with cancer. Three cases in leukemia children and a literature review, Pediatr. Hematol. Oncol. 7:3–12.
Pizzo, P. A., and Walsh, T. J., 1990, Fungal infections in the pediatric cancer patient. Semin. Oncol. 17:6–9.
Damodaran, V. N., and Chakravarty, S. C., 1973, Mechanism of production of Candida lesions in rabbits, J. Med. Microbiol. 6:287–292.
Peterson, E. M., and Calderone, R. A., 1977, Growth inhibition of Candida albicans by rabbit alveolar macrophages, Infect. Immun. 15;910–915.
Peterson, E. M., and Calderone, R. A., 1978, Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages, Infect. Immun. 21: 506–513.
Patterson-Delafield, J., Szklarek, D., Martinez, R. J., and Lehrer, R. I., 1981, Microbicidal cationic proteins of rabbit alveolar macrophages: amino acid composition and functional attributes, Infect. Immun. 31:723–731.
Selsted, M. E., Brown, D. M., DeLange, R. J., and Lehrer, R. I., 1983, Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages, J. Biol. Chem. 258:14485–14489.
Ganz, T., Sherman, M. P., Selsted, M. E., and Lehrer, R. I., 1985, Newborn rabbit alveolar macrophages are deficient in two microbicidal cationic peptides, MCP-1 and MCP-2, Am. Rev. Respir. Dis. 132:901–904.
D’Ambola, J. B., Sherman, M. P., Tashkin, D. P., Gong, H., Jr., 1988, Human and rabbit newborn lung macrophages have reduced anti-Candida activity, Pediatr. Res. 24:285–290.
LaForce, F. M., Sharrar, R. G., and Arai, G., 1979, Characterization of yeast agglutinins in lavage fluid from lungs of rabbits, J Infect. Dis. 140:96–104.
Arai, T., Mikami, Y., and Yokoyama, K., 1977, Phagocytosis of Candida albicans by rabbit alveolar macrophages and guinea pig neutrophils, Sabouraudia 15:171–177.
Gontijo, P. P., Jr., and Wayne, L. G., 1978, Phagocytic and antimicrobial activities of rabbit peritoneal and alveolar macrophages activated with Mycobacterium bovis BCG on Candida albicans, Rev. Latinoam. Microbiol. 20:41–44.
Evans, Z. A., 1980, Tissue responses to the blastospores and hyphae of Candida albicans in the mouse, J. Med. Microbiol. 14:307–319.
Nugent, K. M., and Onofrio, J. M., 1983, Pulmonary tissue resistance to Candida albicans in normal and in immunosuppressed mice, Am. Rev. Respir. Dis. 128:909–914.
Lal, S., Mitsuyama, M., Amako, K., and Nomoto, K., 1986, Enhanced clearance of Candida albicans from lung after intratracheal immunization, J Clin. Lab. Immunol. 21:23–30.
Lal, S., Mitsuyama, M., Miyata, M., Ogata, N., Amako, K., and Nomoto, K., 1986, Pulmonary defense mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans, J. Clin. Lab. Immunol. 19: 127–133.
Nugent, K. M., and Fick, R. B., Jr., 1987,Candidacidal factors in murine bronchoalveolar lavage fluid, Infect. Immun. 55:541–546.
Warr, G. A., and Jakab, G. J., 1979, Alterations in lung macrophage antimicrobial activity associated with viral pneumonia, Infect. Immun. 26:492–497.
Kurland, G., Cheung, A. T., Miller, M. E., Ayin, S. A., Cho, M. M., and Ford, E. W, 1988, The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys, Pediatr. Res. 23:293–297.
Brummer, E., and Stevens, D. A., 1987, Activation of pulmonary macrophages for fungicidal activity by gamma-interferon or lymphokines, Clin. Exp. Immunol. 70:520–528.
Stanley, V. C., and Hurley, R., 1969, The growth of Candida species in cultures of mouse peritoneal macrophages, J. Pathol. 97:357–366.
Ozato, K., and Uesaka, I., 1974, The role of macrophages in Candida albicans infection in vitro, Jap. J Microbiol. 18:29–35.
Sasada, M., and Johnston, R. B., Jr., 1980, Macrophage microbicidal activity: correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages, J. Exp. Med. 152:85–98.
Nozawa, R. T., Sekiguchi, R., and Yokota, T., 1980, Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, muramyl dipeptide of candidacidal activity of mouse macrophages, Cell. Immunol. 53:116–124.
Maiti, P. K., Kumar, R., and Mohapatra, L. N., 1980, Candidacidal activity of mouse macrophages in vitro, Infect. Immun. 29:477–482.
Mor, N., and Goren, M. B., 1987,Discrepancy in assessment of phagosome-lysosome fusion with two lysosomal markers in murine macrophages infected with Candida albicans, Infect. Immun. 55:1663–1667.
Brummer, E., Morrison, C. J., and Stevens, D. A., 1985, Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi, Infect. Immun. 49: 724–730.
Kolotila, M. P., Smith, C. W, and Rogers, A. L., 1987, Candidacidal activity of macrophages from three mouse strains as demonstrated by a new method: neutral red staining, J. Med. Vet. Mycol. 25:283–290.
Lehrer, R. I., Ferrari, L. G., and Patterson-Delafield, J., 1977, The fungicidal activity of rabbit macrophages, Clin. Res. 25:490A.
Kagaya, K., and Fukazawa, Y., 1981, Murine defense mechanisms against Candida albicans infection. II. Opsonization, phagocytosis and intracellular killing of C. albicans, Microbiol. Immunol. 25:807–818.
Brummer, E., and Stevens, D. A., 1989, Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon, J Med. Microbiol. 28:173–181.
Diamond, R. D., and Haudenschild, C. C., 1981, Monocyte-mediated serum independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro, j Clin. Invest. 67: 173–182.
Patterson-Delafield, J., Martinez, R. J., and Lehrer, R. I., 1980, Microbicidal cationic proteins in rabbit alveolar macrophages: a potential host defense mechanism, Infect. Immun. 30:180–192.
Lehrer, R. I., Szklarek, D., Selsted, M. E., and Fleischmann, J., 1981, Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant, Infect. Immun. 33:775–778.
Mourad, S., and Friedman, L., 1961, Active immunization of mice against Candida albicans, Proc. Soc. Exp. Biol. Med. 106:570–572.
Oblack, D. L., and Holder, I. A., 1979, Active immunization of mice against muscle damage mediated by Candida albicans, j Med. Microbiol. 12:503–506.
Banerjee, U., Mohapatra, L. N., and Kumar, R., 1985, Effect of immunization with formalin killed cells in complete Freund’s adjuvant in experimental candidosis, Indian J Med. Res. 81:454–458.
Levy, R., Segal, E., and Eylan, E., 1981, Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions, Infect. Immun. 31:874–878.
Kuttin, E. S., Muller, J., Douchet, C., and Vogt, A., 1983, Immunological and pathological observations with Candida albicans-infected animals, Sabouraudia 21:185–194.
Hasenclever, H. E, and Mitchell, W. 0., 1963, Acquired immunity to candidiasis in mice, J. Bacteriol. 86:401–406.
Giger, D. K., Domer, J. E., and McQuitty, J. T., Jr., 1978, Experimental murine candidiasis: pathologic and immune responses to cutaneous inoculation with Candida albicans, Infect. Immun. 19:499–509.
Scheld, W. M., Calderone, R. A., Brodeur, J. P., and Sande, M. A., 1983, Influence of preformed antibody on the pathogenesis of experimental Candida albicans endocarditis, Infect. Immun. 40:950–955.
Mourad, S., and Friedman, L., 1968, Passive immunization of mice against Candida albicans, Sabouraudia 6:103–105.
Al-Doory, Y., 1970, An immune factor in baboon anti-Candida serum, Sabouraudia 8: 41–47.
Pearsall, N. N., Adams, B. L., and Bunni, R., 1978, Immunologic responses to Candida albicans. III. Effect of passive transfer of lymphoid cells or serum on murine candidiasis, J. Immunol. 120:1176–1180.
Moser, S. A., and Domer, J. E., 1980, Effects of cyclophosphamide on experimental murine candidiasis, Infect. Immun. 27:376–386.
Kuruganti, U., Henderson, L. A., Garner, R. E., Asofsky, R., Baker, P. J., and Domer, J. E., 1988, Nonspecific and Candida-specific immune responses in mice suppressed by chronic administration of anti-g, J Leukoc. Biol. 44:422–433.
Matthews, R., Burnie, J., Smith, D., Clark, I., Midgley, J., Conolly, M., and Gazzard, B., 1988, Candida and AIDS: evidence for protective antibody, Lancet 2:263–266.
Domer, J. E., and Hector, R. H., 1987, Enhanced immune responses in mice treated with penicillin/tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans, Antimicrob. Agents Chemother. 31:691–697.
Hurd, R. C., and Drake, C. H., 1953, Candida albicans infections in actively and passively immunized animals, Mycopathol. Mycol. Appi. 6:290–297.
Miyake, T, Takeya, K., Nomoto, K., and Muraoka, S., 1977, Cellular elements in the resistance to Candida infection in mice. I. Contribution of T lymphocytes and phagocytes at various stages of infection, Microbiol. Immunol. 21:703–725.
Banerjee, U., Mohapatra, L. N., and Kumar, R., 1984, Role of antibody in defence against murine candidosis, Indian J. Med. Res. 79:760–765.
Giger, D. K., Domer, J. E., Moser, S. A., and McQuitty, J. T., Jr., 1978, Experimental murine candidiasis: pathological and immune responses in T-depleted mice, Infect. Immun. 21: 729–737.
Grubek, H., Szymanska, D., Trenkner, E,. Weyman-Rzucidlo, D., and Okon, M., 1970, Effect of anti-lymphocyte serum on experimental infection with Candida albicans in guinea pigs, Acta Microbiol. Pol. Ser. A 2:21–30.
Sohnle, P. G., Frank, M. M., and Kirkpatrick, C. H., 1976, Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs, J. Immunol. 117:523–530.
Cenci, E., Romani, L., Vecchiarelli, A., Puccetti, P., and Bistoni, E, 1989, Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice, Infect. Immun. 59:3581–3587.
Cenci, E., Romani, L., Vecchiarelli, A., Puccetti, P., and Bistoni, E, 1990, T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice, J. Immunol. 144:4333–4339.
Vecchiarelli, A., Cenci, E., Puliti, M., Blasi, E., Puccetti, P., Cassone, A., and Bistoni, E, 1989, Protective immunity induced by low-virulence Candida albicans: cytokine production in the development of the anti-infectious state, Cell. Immunol. 124:334–344.
Garner, R. E., Kuruganti, U., Czarniecki, C. W, Chiu, H. H., and Domer, J. E., 1989, In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon, Infect. Immun. 57:1800–1808.
Sen, P., Smith, J. K., Buse, M., Hsieh, H. C., Lavenhar, M. A., Lintz, D., and Louria, D. B., 1982, Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract, Sabouraudia 20:85–93.
Kagaya, K., Shinoda, R., and Fukazawa, Y., 1981, Murine defense mechanisms against Candida albicans infection. I. Collaboration of cell-mediated and humoral immunities in protection against systemic C. albicans infection, Microbiol. Immunol. 25:647–654.
Sinha, B. K., Prasad, S., and Monga, D. P., 1987, Studies of experimental candidiasis in T-cell-deficient mice, Zbt. Bacteriol. Hyg. A 256:203–209.
Ashman, R. B., 1990, Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection, Immunol. Cell Biol. 68:15–20.
Hurtrel, B., Lagrange, P. H., and Michel, J.-C., 1981, Absence of correlation between delayed-type hypersensitivity and protection in experimental systemic candidiasis in immunized mice, Infect. Immun. 31:95–101.
Salvin, S. B., Peterson, R. D. A., and Good, R. A., 1965, The role of the thymus in resistance to infection and endotoxin toxicity,. Lab. Clin. Med. 65:1004–1022.
Gordee, R. S., and Simpson, P. J., 1967, Relationships of x-irradiation to the enhancement of Candida albicans infections, J. Bacterial. 94:6–12.
Rogers, T. J., Balish, E., and Manning, D. D., 1976, The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis,J. Reticuloendothel. Soc. 20:291–298.
Ashman, R. B., 1987, Mouse candidiasis. II. Host responses are T-cell dependent and regulated by genes in the major histocompatibility complex, Immunogenetics 25: 200–203.
Sinha, B. K., Prasad, S., and Monga, D. P., 1987, Studies on the role of B-cells in the resistance of mice to experimental candidiasis, Zbl. Bakt. Hyg. A 266:316–322.
Mahanty, S., Greenfield, R. A., Joyce, W. A., and Kincade, R W, 1988, Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome, Infect. Immun. 56:3162–3166.
Marquis, G., Montplaisir, S., Pelletier, M., Auger, R, and Lapp, W. S., 1988, Genetics of resistance to infection with Candida albicans in mice, Br J. Exp. Path. 69:651–660.
Vecchiarelli, A., Cenci, E., Marconi, R, Rossi, R., Riccardi, C., and Bistoni, E, 1989, Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans, J. Med. Microbial. 30;183–192.
Bistoni, E, Marconi, R, Frati, L., Bonmassar, E., and Garcia, E., 1982, Increase of mouse resistance to Candida albicans infection by thymosin al, Infect. Immun. 36:609–614.
Marquis, G., Montplaisir, S., Pelletier, M., Mousseau, S., and Auger, R, 1986, Strain-dependent differences in susceptibility of mice to experimental candidosis, j Infect. Dis. 154:906–909.
Ashman, R. B., and Papadimitriou, J. M., 1987, Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice, Immunol. Cell Biol. 65:163–171.
Ashman, R. B., 1990, Murine candidiasis: susceptibility is associated with the induction of T cell-mediated, strain-specific autoreactivity, Immunol. Cell Biol. 68:179–185.
Ashman, R. B., 1987, Murine candidiasis. III. Host inflammatory responses are regulated in part by class I MHC genes, J Immunogenet. 14:317–321.
Ashman, R. B., and Papadimitriou, J. M., 1989, Genetic regulation of pathogenesis and host responses in fungal infection, in Immunology of Fungal Diseases (E. Kurstak, ed.), Marcel Dekker, Inc., New York, pp. 347–371.
Fischer, A., Ballet, J. J., and Griscelli, C., 1978, Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in serum of patients with chronic mucocutaneous candidiasis, j Clin. Inzest. 62:1005–1013.
Witkin, S. S., Yu, R., and Ledger, W. J., 1983, Inhibition of Candida albicans-induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis, Am. J. Obstet. Gynecol. 147:809–811.
Borkowsky, W, and Valentine, E T., 1979, The proliferative response of human lymphocytes to antigen is suppressed preferentially by lymphocytes precultured with the same antigen, J Immunol. 122:1867–1873.
Rogers, T. J., and Balish, E., 1978, Effect of systemic candidiasis on blastogenesis of lymphocytes from germfree and conventional rats, Infect. Immun. 20:142–150.
Skerl, K. G. Scheld, W. M., Alliegro, G. M., and Calderone, R. A., 1980, Lymphocyte blastogenesis during experimental endocarditis caused by Candida albicans, J. Reticuloendothel. Soc. 28:495–506.
Piccolella, E., Lombardi, G., and Morelli, R., 1981, Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicanu,J. Immunol. 126: 2151–2159.
Rivas, V, and Rogers, T. J., 1983, Studies on the cellular nature of Candida albicans-induced suppression. J Immunol. 130:376–379.
Cuff, C. E, Rogers, C. M., Lamb, B.J., and Rogers, T. J., 1986, Induction of suppressor cells in vitro by Candida albicans, Cell. Immunol. 100:47–56.
Nelson, R. D., Herron, M. J., McCormack, R. T., and Gehrz, R. C., 1984, Two mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharide, Infect. Immun. 43:1041–1046.
Witkin, S. S., 1986, Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans, Obstet. Gynecol. 68:696–699.
Podzorski, R. P., Herron, M. J., Fast, D. J., and Nelson, R. D., 1989, Pathogenesis of candidiasis. Immunosuppression by cell wall mannan catabolites, Arch. Surg. 124:1290–1294.
Podzorski, R. E, Gray, G. R., and Nelson, R. D., 1990, Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro, J. Immunol. 144;707–716.
Cuff, C. E, Packer, B. J., and Rogers, T. J., 1989, A further characterization of Candida albicans-induced suppressor B-cell activity, Immunology 68:80–86.
Cuff, C. E, Taub, D. D., and Rogers, T. J., 1989, The induction of T-suppressor cells with a soluble extract of Candida albicans, Cell. Immunol. 122:71–82.
Segal, E., Schwartz, J., Altboun, Z., Vardinon, N., and Eylan, E., 1977, Suppressive action of Candida albicans on the immune response in guinea pigs,.Vlicrobios 19:79–87.
Vardinon, N., and Segal, E., 1979, Suppressive action of Candida albicans on the immune response in mice, Exp. Cell Biol. 47:275–280.
Segal, E., Sandovsky-Losica, H., and Vardinon, N., 1980, Suppressive action of cytoplasmic and metabolic extracts of Candida albicans on the immune response in guinea pigs, Mycopathologia 72:121–128.
Cutler, J. E., and Lloyd, R. K., 1982, Enhanced antibody responses induced by Candida albicans in mice, Infect. Immun. 38:1102–1108.
Carroty, E. W, and Domer, J. E., 1985, Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein, Infect. Immun. 49:172–181.
Domer, J. E., Stashak, P. W, Elkins, K., Prescott, B., Caldes, G., and Baker, P. J., 1986, Separation of immunomodulatory effects of mannan from Candida albicans into stimulatory and suppressive components, Cellular Immunol. 101:403–414.
Domer, J. E., Elkins, K. L., Ennist, D. L., Stashak, P. W, Garner, R. E., and Baker, E J., 1987, Immunoenhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein, Infect. Immun. 55:2619–2624.
Domer, J., Garner, R., and Befidi-Mengue, R., 1989, Mannan as an antigen in cell-mediated immune (CMI) assays and as a modulator of mannan-specific CMI, Infect. Immun. 57: 693–700.
Garner, R. E., Childress, A. M., Human, L. G., and Domer, J. E., 1990, Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells, Infect. Immun. 58:2613–2620.
Piccolella, E., Lombardi, G., and Morelli, R., 1980, Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response, J. Immunol. 125:2082–2088.
Lombardi, G., Vismara, D., Piccolella, E., Colizzi, V., and Asherson, G. L., 1985, A nonspecific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production, Clin. Exp. Immunol. 60:303–310.
Peat, S., Whelan, W. J., and Edwards, T. E., 1961, Polysaccharide of baker’s yeast. Part IV. Mannan, J. Chem. Soc. (London) 1:29–34.
Durandy, A., Fischer, A., Charron, D., and Griscelli, G., 1986, Specific binding of antigen onto human T lymphocytes, J. Clin. Invest. 77:1557–1564.
Fischer, A., Pichat, L., Audinot, M., and Griscelli, C., 1982, Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness, Clin. Exp. Immunol. 47:653–660.
Wright, C. D., Herron, M. J., Gray, G. R., Holmes, B., and Nelson, R. D., 1981, Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme, Infect. Immun. 32:731–738.
Winner, H. I., and Hurley, R., 1964, Candida Albicans, J. and A. Churchill Ltd, London.
Taschdjian, D. L., Kozinn, P. J., and Caroline, L., 1964, Immune studies in candidiasis. III. Precipitating antibodies in systemic candidiasis, Sabouraudia 3:312–320.
de Repentigny; L., and Reiss, E., 1984, Current trends in immunodiagnosis of candidosis and aspergillosis, Rev. Infect. Dis. 6:301–312.
Bennett, J. E., 1987, Rapid diagnosis of candidiasis and aspergillosis, Rev. Infect. Dis. 9: 398–402.
de Repentigny, L., 1989, Serological techniques for diagnosis of fungal infection, Eui: J. Clin.Vlicrobiol. Infect. Dis. 81:362–375.
Evans, E. G. V, Richardson, M. D., Odds, E C., and Holland, K. T., 1973, Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis, Br: Med. J. 4:86–87.
Syverson, R. E., Buckley, H. R., and Campbell, C. C., 1975, Cytoplasmic antigens unique to the mycelial or yeast phase of Candida albicans, Infect. Immun. 12:1184–1188.
Manning, M., and Mitchell, T. G., 1980, Morphogenesis of Candida albicans and cytoplasmic proteins associated with differences in morphology; strain, or temperature, Bacteriol. 144: 258–273.
Ho, Y. M., Ng, M. H., and Huang, C. T., 1979, Antibodies to germinating and yeast cells of Candida albicans in human and rabbit sera, J. Clin. Pathol. 32:399–405.
Smail, E. H., and Jones, J. M., 1984, Demonstration and solubilization of antigens expressed primarily on the surfaces of Candida albicans germ tubes, Infect. Immun. 45:74–81.
Sundstrom, P. M., and Kenny, G. E., 1984, Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence, Infect. Immun. 43: 850–855.
Ponton, J., and Jones, J. M., 1986, Analysis of cell wall extracts of Candida albicans by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blot techniques, Infect. Immun. 53:565–572.
Brawner, D. J., and Cutler, J. E., 1984, Variability in expression of a cell surface determinant as evidenced by an agglutinating monoclonal antibody, Infect. Immun. 43:966–972.
Brawner, D. J., and Cutler, J. E., 1986, Variability in expression of cell surface antigens of Candida albicans during morphogenesis, Infect. Immun. 51;337–343.
Chaffin, W. L., Skudlarek, J., and Morrow, K. J., 1988, Variable expression of a surface determinant during proliferation of Candida albicans, Infect. Immun. 56:302–309.
Summers, D. E, Grollman, A. E, and Hasenclever, H. E, 1964, Polysaccharide antigens of Candida cell wall, J. Immunol. 92:491–499.
Syverson, R. E., and Buckley, H. R., 1977, Cell wall antigens in soluble cytoplasmic extracts of Candida albicans as demonstrated by crossed-immunoelectrophoresis with concanavalin A, J Immunol. Methods 18:149–156.
Munoz, M., Estes, G., Kilpatrick, M., DiSalvo, A., and Virella, G., 1980, Purification of cytoplasmic antigens from the mycelial phase of Candida albicans: possible advantages of its use in Candida serology, Mycopathologia 72:47–53.
Taschdjian, C. L., Dobbin, G. B., Kozinn, P. J., and Caroline, L., 1964, Experimental and preliminary clinical studies on antibody formation in systemic candidiasis, Sabouraudia 3: 129–139.
Remington, J. S., Gaines, J. D., and Gilmer, M. A., 1972, Demonstration of Candida precipitins in human sera by counter-immunoelectrophoresis, Lancet 1:413.
Axelsen, N. H., Buckley, H. R., Drouhet, E., Budtz-Jorgensen, E., Hattel, T., and Andersen, P. L., 1975, Crossed immunoelectrophoretic analysis of precipitins to Candida albicans in deep Candida infection, Scand. J Immunol. 4:217–230.
Lehmann, P. E, and Reiss, E., 1980, Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients, Mycopathologia 70: 89–93.
Meckstroth, K. L., Reiss, E., Keller, J. W, and Kaufman, L., 1981, Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay, J. Infect. Dis. 144:24–32.
Odds, E C., Evans, E. G. V., and Holland, K. T., 1975, Detection of Candida precipitins. A comparison of double diffusion and counter immunoelectrophoresis, J. Immunol. Methods 7: 211–218.
Harding, S. A., Sanford, G. R., and Merz, W. G., 1976, Three serologic tests for candidiasis. Diagnostic value in distinguishing deep or disseminated infection from superficial infection or colonization, Am. J. Clin. Pathol. 65:1001–1009.
Dee, T. H., and Rytel, M. W, 1977, Detection of Candida serum precipitins by counterimmunoelectrophoresis: an adjunct in determining significant candidiasis, J. Clin. Microbiol. 5:453–457.
Merz, W. G., Evans, G. L., Shadomy, S., Anderson, S., Kaufman, L., Kozinn, P. J., Mackenzie, D. W, Protzman, W. P., and Remington, J. S., 1977, Laboratory evaluation of serological tests for systemic candidiasis: a cooperative study, J Clin. Microbiol. 5:596–603.
Kozinn, P. J., Taschdjian, C. L., Goldberg, P. K., Protzmann, W. P., Mackenzie, D. W. R., Remington, J. S., Anderson, S., and Seelig, M. S., 1978, Efficacy of serological tests in the diagnosis of systemic candidiasis, Am. J Clin. Pathol. 70:893–898.
Dee, T. H., Johnson, G. M., and Berger, C. S., 1981, Sensitivity specificity, and predictive value of anti-Candida serum precipitin and agglutinin quantification: comparison of counterimmunoelectrophoresis and latex agglutination, j Clin. Microbiol. 13:750–753.
Bisbe, J., Miro, J. M., Torres, J. M., Latorre, X., Alia, C., Amaral, M., Estivill, D., Mallalas, J., Trilla, A., and Soriano, E., 1989, Diagnostic value of serum antibody and antigen detection in heroin addicts with systemic candidiasis, Rev. Infect. Dis. 11:310–315.
Syverson, R. E., Buckley, H. R., and Gibian, B. A., 1978, Increasing the predictive value positive of the precipitin test for the diagnosis of deep-seated candidiasis, Am. J. Clin. Pathol. 70:826–831.
Glew, R. H., Buckley, H. R., Rosen, H. M., Moellering, R. C., and Fischer, J. E., 1978, Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoresis, Am. J. Med. 64:586–591.
Poulain, D., and Pinon, J. M., 1986, Diagnosis of systemic candidiasis: development of cocounterimmunoelectrophoresis, Eur. j Clin. Microbiol. 5:420–426.
Poulain, D., and Pinon, J. M., 1986, Application of co-counterimmunoelectrophoresis, Eur. J. Clin Microbiol. 5:427–434.
Bougnoux, M.-E., Hill, C., Moissenet, D., de Chavin, M. E, Bonnay, M., Vicens-Sprauel, I., Pietri, F., McNeil, M., Kaufman, L., Dupouy-Camet, J,. Bohuon, C., and Andremont, A., 1990, Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis, J. Clin. Microbiol. 28:905–909.
Jones, J. M., 1980, Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice and humans, Infect. Immun. 30:78–89.
Matthews, R. C., Burnie, J. P., and Tabaqchali, S., 1984, Immunoblot analysis of the serologic response in systemic candidosis, Lancet 2:1415–1418.
Au-Young, J. K., Troy, E. A., and Goldstein, E., 1985, Serologic analysis of antigen-specific reactivity in patients with systemic candidiasis, Diag. Microbiol. Infect. Dis. 3:419–432.
Gatermann, S., Heesemann, J., and Laufs, R., 1986, Identification of Candida albicans antigens recognized by sera of patients with candidiasis, Mykosen 29:343–354.
Strockbine, N. A., Largen, M. T., Zweibel, S. M., and Buckley, H. R., 1984, Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera, Infect. Immun. 43:715–721.
Porsius, J. C., van Vleit, H. J., van Zeijl, J. H., Goessens, W. H., and Michel, M. E, 1990, Detection of an antibody response in immunocompetent patients with systemic candidiasis or Candida albicans colonization, Eur. J. Clin. Microbiol. Infect. Dis. 9:352–355.
Greenfield, R. A., and Jones, J. M., 1981, Purification and characterization of a major cytoplasmic antigen of Candida albicans, Infect. Immun. 34:469–477.
Fiss, E., and Buckley, H. R., 1987, Purification of actin from Candida albicans and comparison with the Candida 48,000-Mr Protein, Infect. Immun. 55:2324–2326.
Mason, A. B., Brandt, M. E., and Buckley, H. R., 1989, Enolase activity associated with Candida albicans cytoplasmic antigen, Yeast 5:231–239.
Franklyn, K. M., Warmington, J. R., Ott, A. K., and Ashman, R. B., 1990, An immunodominant antigen of Candida albicans shows homology to the enzyme enolase, Immunol. Cell Biol. 68:173–178.
Matthews, R. C., Burnie, J. P., and Tabaqchali, S., 1987, Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans, J. Clin. Microbiol. 25:230–237.
Matthews, R., Wells, C., and Burnie, J. P., 1988, Characterization and cellular localization of the immunodominant 47-Kda antigen of Candida albicans, J. Med. Microbiol. 27:227–232.
Manning-Zweerink, M., Maloney, C. S., Mitchell, T. G., and Weston, H., 1986, Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera, J Clin. Microbiol. 23:46–52.
Reen, D. J., 1988, Assessment of immunoblotting in the investigation of specific immune responses during infection, Biochem. Soc. Trans. 16:132–134.
Weller, B. I., Simmons, P. D., Ivanyl, L., 1990, Identification of immunodominant antigens of Candida albicans in patients with superficial candidosis, Clin. Immunol. Immunopathol. 54: 347–353.
Greenfield, R. A., Bussey, M. J., Stephens, J. L., and Jones, J. M., 1983, Serial enzyme-linked immunosorbent assays for antibody to Candida antigens during induction chemotherapy for acute leukemia, J. Infect. Dis. 148:275–283.
Strockbine, N. A., Largen, M. T., and Buckley, H. R., 1984, Production and characterization of three monoclonal antibodies to Candida albicans proteins, Infect. Immun. 43:1012–1018.
Ho, Y. M., Ng, M. H., Teoh-Chan, C. H., Yue, P. C. K., and Huang, C. T., 1976, Indirect immunofluorescence assay for antibody to germ tube of Candida albicans-a new diagnostic test, J. Clin. Pathol. 29:1007–1010.
Quindos, G., Ponton, J., and Cisterna, R., 1987, Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis, Eur. J. Clin. Microbiol. 6:142–146.
Quindos, G., Ponton, J., Cisterna, R., and Mackenzie, D. W. R., 1990, Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis, Eur. J. Clin. Microbiol. Infect. Dis. 9:178–183.
McHugh, T. M., Wang, Y. J., Chong, H. O., Blackwood, L. L., and Stites, D. P., 1989, Development of a microsphere-based fluorescent immunoassay and its comparison to an enzyme immunoassay for the detection of antibodies to three antigen preparations from Candida albicans, J Immunol. Methods 116:213–219.
Weiner, M. H., and Yount, W J., 1976, Mannan antigenemia in the diagnosis of invasive Candida infections, J. Clin. Invest. 58:1045–1053.
Kerkering, T. M., Espinel-Ingroff, A., and Shadomy, S., 1979, Detection of Candida antigenemia by counterimmunoelectrophoresis in patients with invasive candidiasis, J. Infect. Dis. 140:659–664.
Weiner, M. H., and Coats-Stephen, M., 1979, Immunodiagnosis of systemic candidiasis: mannan antigenemia detected by radioimmunoassay in experimental and human infections, J. Infect. Dis. 140:989–993.
Segal, E., Berg, R. A., Pizzo, P. A., and Bennett, J. E., 1979, Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique, J. Clin. Microbiol. 10:116–118.
Reiss, E., Stockman, L., Kuykendall, R. J., and Smith, S. J., 1981, Dissociation of mannanserum complexes and detection of Candida albicans mannan by enzyme immunoassay variations, Clin. Chem. 28:306–310.
Lew, M. A., Siber, G. R., Donahue, D. M., and Maiorca, E, 1982, Enhanced detection with an enzyme-linked immunosorbent assay of Candida mannan in antibody-containing serum after heat extraction, J. Infect. Dis. 145:45–56.
Lemieux, C., St-Germain, G., Vincelette, J., Kaufman, L., and deRepentigny, L., 1990, Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis, J. Clin. Microbiol. 28: 249–253.
Kahn, E. W, and Jones, J. M., 1986, Latex agglutination test for detection of Candida antigens in sera of patients with invasive candidiasis, J Infect. Dis. 153:579–585.
deRepentigny, L., Marr, L. D., Keller, J. W, Carter, A. W, Kuykendall, R. J., Kaufman, L., and Reiss, E., 1985, Comparison of enzyme immunoassay and gas—liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients, J. Clin. Microbiol. 21: 972–979.
Phillips, E, Dowd, A., Jewesson, E, Radigan, G., Tweeddale, M. G., Clarke, A., Geere, I., and Kelly, M., 1990, Nonvalue of antigen detection immunoassays for diagnosis of candidemia, J. Clin. Microbiol. 28:2320–2326.
Fung, J. C., Donta, S. T, and Tilton, R. C., 1986, Candida detection system (CAND-TEC) to differentiate between colonization and disease, J. Clin. Microbiol. 24:542–547.
Fujita, S., Matsubara, E, and Matsuda, T., 1986, Enzyme-linked immunosorbent assay measurement of fluctuations in antibody titer and antigenemia in cancer patients with and without candidiasis, J. Clin. Microbiol. 23:568–575.
Gentry, L. O., Wildinson, I. D., Lea, S. S., and Price, M. E, 1983, Latex agglutination test for detection of Candida antigen in patients with disseminated disease, Eur. J. Clin. Microbiol. 2: 122–128.
Piens, M.-A., Guyotat, D., Archimbaud, E., Plotton, C., Maupas, J., Mojon, M., and Fiere, D., 1988, Evaluation of a Candida antigen detection test (Cand-TecTM) in the diagnosis of deep candidiasis in neutropenic patients, Eur. J. Cancer Clin. Oncol. 24:1655–1659.
Ness, M. J., Vaughan, W. P., and Woods, G. L., 1989, Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients, J. Infect. Dis. 159:495–502.
Escuro, R. S., Jacobs, M., Gerson, S. L., Machicao, A. R., and Lazarus, H. M., 1989, Prospective evaluation of a Candida antigen detection test for invasive candidiasis in immunocompromised adult patients with cancer, Am. J. Med. 87:621–627.
Price, M. E, and Gentry, L. O., 1990, Candida antigen latex test, J. Infect. Dis. 161:807.
Price, M. E, and Gentry, L. O., 1986, Incidence and significance of Candida antigen in low-risk and high-risk patient populations, Eur. J. Clin. Microbiol. 5:416–419.
Bailey, J. W, Sada, E., Brass, C., and Bennett, J. E., 1985, Diagnosis of systemic candidiasis by latex agglutination for serum antigen, J Clin. Microbiol. 21:749–752.
Ness, M. J., Rennard, S. I., Vaughn, W. P., Ghafouri, M. A., and Linder, J. A., 1988, Detection of Candida antigen in bronchoalveolar lavage fluid, Acta Cytol. 32:347–352.
Araj, G. E, Hopfer, R. L., Chesnut, S., Fainstein, V., and Bodey, G. R, 1982, Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients, J. Clin. Microbiol. 16:46–52.
Burnie, J., 1985, A reverse passive latex agglutination test for the diagnosis of systemic candidosis, J. Immunol. Methods 82:267–280.
Ferraira, R. R, Yu, B., Niki, Y., and Armstrong, D., 1990, Detection of Candida antigenuria in disseminated candidiasis by immunoblotting, J Clin. Microbiol. 28:1075–1078.
Longbottom, J. J., Murray, I. G., and Pepys, J., 1963, Diagnosis of fungal disease, in: Clinical Aspects of Immunology, (P. L. Gell and R. R. A. Coombs, eds.), Blackwell Scientific Publications, Oxford, p. 71.
Shannon, D. C., Gohnson, G., Rosen, E. S., and Austen, K. E, 1966, Cellular reactivity to Candida albicans antigen, N. Engl. J. Med. 275:690–693.
Hassett, A. M., Woods, R. J., Temperley, I. J., and Mullins, G. M., 1977, Cell mediated immunity to recall antigens in vivo and in vitro, Irish J. Med. Sci. 146:167–174.
Ferguson, A. C., Kershnar, H. E., Collin, W. K., and Stiehm, E. R., 1977, Correlation of cutaneous hypersensitivity with lymphocyte response to Candida albicans, Am. J. Clin. Pailful. 68:499–540.
Hogan, T. E, Borden, E. C., Freeberg, B. L., Vieau, J., Hsieh, E.-Y., and Crowley, J., 1980, Enhancement in recall antigen responses by frequent, repetitive skin testing with Candida, mumps, and streptokinase-streptodornase in 38 normal adults, Cancer Immunol. Immunother. 10:27–31.
Valdimarsson, H., Higgs, J. M., Wells, R. S., Yamamura, M., Hobbs, J. R., and Holt, P. J. L., 1973, Immune abnormalities associated with chronic mucocutaneous candidiasis, Cellular Immunol. 6:348–361.
Bice, D. E., Lopez, M., Rothschild, H., and Salvaggio, J., 1974, Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer, Int. Arch. Allergy 47:54–62.
Alford, R. H., 1973, Transformation of lymphocytes of normal and hospitalized adults by Candida albicans extract, Proc. Soc. Exp. Biol. Med. 144:826–829.
Foroozanfar, N., Yamamura, M., and Hobbs, J. R., 1974, Standardization of lymphocyte transformation to Candida immunogen, Clin. Exp. Immunol. 16:301–310.
Esch, R. E., and Buckley, C. E., 1988, A novel Candida albicans skin test antigen: efficacy and safety in man, J. Biol. Standardization 16:33–43.
Hurtrel, B., and Lagrange, P. H., 1978, Delayed type hypersensitivity reactions to Candida albicans in mice, Ann. D’Immunol. C129:653–668.
Ponton, J., Quindos, G., Regulez, P., and Cisterna, R., 1985, Cellular and humoral immune responses to Candida-albicans in subcutaneously infected mice, Mycopathologia 92:11–18.
Suzuki, M., and Hayashi, Y., 1975, Skin reaction and macrophage migration inhibition tests for polysaccharides from Aspergillus fumigatus and Candida albicans, Jap. J. Microbiol. 19: 355–362.
Reiss, E., Stone, S. H., and Hasenclever, H. R., 1974, Serologic and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls, Infect. Immun. 9:881–890.
Ellsworth, J. H., Reiss, E., Bradley, R. L., Chmel, H., and Armstrong, D., 1977, Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannans separated by affinity for concanavalin A., J. Clin. Microbiol. 5:91–99.
Domer, J. E., and Moser, S. A., 1978, Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge, Infect. Immun. 20:88–98.
Moser, S. A., Domer, J. E., and Mather, E J., 1980, Experimental murine candidiasis: cell mediated immunity after cutaneous challenge, Infect. Immun. 27:140–149.
Levy, R., Segal, E., Eylan, E., and Barr-Nea, L., 1983, Cell-mediated immunity following experimental vaccinations with Candida albicans ribosomes, Mycopathologia 83:161–168.
Crowle, A. J., 1975, Delayed hypersensitivity in the mouse, Adv. Immunol. 20:197–264.
Dikeacou, R., and Drouhet, E., 1981, Cellular inflammatory response to fungal antigen studied with the skin window technique—correlation of the exudate with the evolution of the mycotic infection, Agents Actions 11:631–633.
Winterrowd, G. E., and Cutler, J. E., 1983, Candida albicans-induced agglutinin and immunoglobulin E responses in mice, Infect. Immun. 41:33–38.
Domer, J. E., 1989, Candida cell wall mannan: a polysaccharide with diverse immunologic properties, CRC Crit. Rev. Microbiol. 17:33–51.
Ausiello, C. M., Spagnoli, G. C., Boccanera, M., Casalinuovo, I., Malavasi, E, Casciani, C. U., and Cassone, A., 1986, Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions, J Med. Microbiol. 22:195–202.
Piccolella, E., Lombardi, G., and Morelli, R., 1980, Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response, J. Immunol. 125:2082–2088.
Gettner, S. M. M., and Mackenzie, D. W. R., 1981, Responses of human peripheral lymphocytes to soluble and insoluble antigens of Candida albicans, j Med. Microbiol. 14: 333–340.
Tollemar, J., Ringden, O., and Holmberg, K., 1989, Candida albicans: mannan and protein activation of cells from various human lymphoid organs, Scand. j Immunol. 30:473–480.
Kerridge, D., and Whelan, W. L., 1984, The polyene macrolide antibiotics and 5-fluorocytosine Molecular actions and interactions, in: Mode of Action of Antifungal Agents (A. P. J. Trinci, and J. E Riley, eds.), London, British Mycological Society, pp. 343–375.
Bennett, J. E., 1990, Antifungal agents, in: Principles and Practice of Infectious Diseases third edition, (G. L. Mandell, R. G. Douglas, and J. E. Bennett, eds.), Churchill Livingstone, New York, pp. 361–370.
Smego, R. A., Jr., Perfect, J. R., Durack, D. T, 1984, Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis, Rev. Infect. Dis. 6:791–801.
Diasio, R. B., Bennett, J. E., and Myers, C. E., 1978, Mode of action of 5-fluorocytosine, Biochem. Pharmacol. 27:703–707.
Polak, A., and Scholer, H. J., 1975, Mode of action of 5-fluorocytosine and mechanisms of resistance, Chemother. 21:113–130.
Vanden Bossche, H., Bellens, D., Cools, W, Gorrens, J., Marichal, P., Verhoeven, H., Willemsens, G., De Coster, R., Beerens, D., Haelterman, C., Coene, M.-C., Lauwers, W, and Le Jeune, L., 1986, Cytochrome P-450: target for itraconazole, Drug Dev. Res. 8:287–298.
Dismukes, W. E., 1988, Azole antifungal drugs: old and new, Ann. Intern. Med. 109: 177–179.
Meunier, E, Gerain, J., Snoeck, R., Libotte, E, Lambert, C., Cueppers, A. M., 1987, Fluconazole therapy of oropharyngeal candidiasis in cancer patients, in: Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents (R. A. Fromtling, ed.), J. R. Prouss, Barcelona, pp. 169–174.
Dupont, B., and Drouhet, E., 1988, Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients, J. Med. Vet. Mycol. 26:67–71.
Meunier-Carpentier, E, Cruciani, M., Klastersky, J., 1983, Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients, Eur. J. Cancer Clin. Oncol. 19:43–48.
Jones, P. G., Kauffmann, C. A., McAuliffe, L. S., Liepman, M. K., and Bergman, A. G., 1984, Efficacy of ketoconazole versus nystatin in prevention of fungal infections in neutropenic patients, Arch. Intern. Med. 144:549–551.
Meunier, E, Leleux, A., Snoeck, R., Gerain, J., Lambert, C,. Cueppers, A. M., 1989, Chemoprophylaxis of fungal infections, in: Diagnosis and Therapy of Systemic Fungal Infections (K. Holmberg, and R. Meyer, eds.), Raven Press, New York, pp. 167–177.
Edwards, J. E., Jr., 1990, Candida species, in: Principles and Practice of Infectious Diseases (G. L. Mandell, R. G. Douglas, and J. E. Bennett, eds.), Churchill-Livingstone, New York, pp. 1943–1958.
Meunier, E, 1989, Candidiasis, Eur. j Clin. Microbiol. Infect. Dis. 8:438 447.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Domer, J.E., Lehrer, R.I. (1993). Introduction to Candida. In: Murphy, J.W., Friedman, H., Bendinelli, M. (eds) Fungal Infections and Immune Responses. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2400-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2400-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2402-5
Online ISBN: 978-1-4899-2400-1
eBook Packages: Springer Book Archive